Stay updated on Carboplatin Combo in Metastatic Triple-Negative Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Carboplatin Combo in Metastatic Triple-Negative Breast Cancer Clinical Trial page.

Latest updates to the Carboplatin Combo in Metastatic Triple-Negative Breast Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no changes to core study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check29 days agoChange DetectedAdditions include Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Deletions include Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check43 days agoChange DetectedRevision: v3.3.4 updated on the page, replacing the previous v3.3.3 version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedLocations information was updated: a new Locations section with Ohio as a study site was added, and related Ohio Locations and HHS Vulnerability Disclosure elements were removed; the page revision was updated to v3.3.3.SummaryDifference0.2%

- Check87 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. No substantive changes to the study information or user-facing content were detected.SummaryDifference0.1%

Stay in the know with updates to Carboplatin Combo in Metastatic Triple-Negative Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin Combo in Metastatic Triple-Negative Breast Cancer Clinical Trial page.